ADDvise extends the agreement with Laborie at a value of SEK 48 million

12-05-2023   Regulatory press release

ADDvise Group’s subsidiary Sonesta Medical AB extends the agreement with Laborie Medical Technologies (“Laborie”). The agreement is giving Laborie the right to sell Sonesta Medical’s urology- and gynecology patient positioning equipment and video fluoroscopy tables worldwide, with an exclusive right to distribute in USA and some European countries. Laborie commits to a minimum volume of SEK 48 million. The term of the agreement is two years. The total value of the orders during the term of the agreement is at least SEK 48 million.

Laborie is a leading global developer, manufacturer and distributor of medical technology and consumables used for diagnostic and therapeutic solutions in urology, urogynecology and gastroenterology. Laborie is a company based in Canada owned by Patricia Industries and a part of Swedish Investor AB.

Important information
This information is information that ADDvise Group AB is required to disclose under the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on 12 May 2023 at 08:40 CEST.

For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se

About ADDvise Group
 ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.

 

Latest press releases

ADDvise increases long-term financial targets

Regulatory

The Board of ADDvise Group AB has decided to update the long-term financial targets for EBITDA margin and revenue growth based on the strong financial performance and the visibility on the upcoming quarters. The EBITDA margin target has been increased from 20% to 28 % and the annual growth target from 25% to 30 %.…

ADDvise announces early redemption of existing bonds 2021/2024

Regulatory

ADDvise Group AB (publ) (the “Company”) announces today that it will redeem in full its outstanding bond loan with ISIN SE0015222088 (the “Bonds” and “Early Redemption”) subject to the successful issuance of new bonds as announced by the Company through a press release on 11 May 2023. Provided that the conditions for Early Redemption are…

ADDvise extends the agreement with Laborie at a value of SEK 48 million

Regulatory

ADDvise Group’s subsidiary Sonesta Medical AB extends the agreement with Laborie Medical Technologies (“Laborie”). The agreement is giving Laborie the right to sell Sonesta Medical’s urology- and gynecology patient positioning equipment and video fluoroscopy tables worldwide, with an exclusive right to distribute in USA and some European countries. Laborie commits to a minimum volume of…